Drawing for APEXCELLA

USPTO serial 99091453

APEXCELLA

Reviewed by CopyMark Law Group

Status 731Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
SAUNDERS, CAROLINE M
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 731: Status 731 means the second six-month extension to file a Statement of Use was granted. File a Statement of Use or the next extension before the deadline expires.

Need help with APEXCELLA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $648*

Plus Government fees of $300

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joseph Bruce

Joseph Bruce BRUCE STONE LLP8888 Keystone CrossingSuite 1300Indianapolis, IN 46240

Goods and services

ClassDescriptionStatusFirst use
005Immunostimulants; Cells for medical use; Biological tissue cultures for medical purposes; Anti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical agents for treating aging, oncology and autoimmune disease; Antivirals; Biocides; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer treatment; Blood for medical purposes; Adjuvants for medical purposes; Pharmaceuticals, namely, immunotherapy being immunostimulators; Pharmaceutical products for the prevention and treatment of cancer; Stem cells for medical purposes; Reagents for medical use; Diagnostic reagents for medical useACTIVE—
042Biological research; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Medical and scientific research, namely, conducting clinical trials for others; Research and development in the pharmaceutical and biotechnology fields; Medical research services; Research and development in the field of cancer immunotherapy; Research and development of new products for others; Technological research in the field of cancer immunotherapy; Conducting of feasibility studies in the field of new technologies; Technical writing for others; Scientific laboratory services; Scientific research; Technological consultancy services in the field of cancer immunotherapy; Scientific and technological research relating to cancer immunotherapy; Culturing of cells for others for scientific research purposes; New product design services; Custom design of prototypes; Quality control of goods and services; Product quality testing servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 11, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 10, 2026EX2GSOU EXTENSION 2 GRANTED—
Nov 10, 2026EXT2SOU EXTENSION 2 FILED—
Nov 10, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 17, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 17, 2026EX1GSOU EXTENSION 1 GRANTED—
Apr 17, 2026EXT1SOU EXTENSION 1 FILED—
Apr 17, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 18, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 23, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 23, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 17, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 21, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 19, 2025DOCKASSIGNED TO EXAMINER—
Aug 5, 2025MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Aug 5, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 19, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 19, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance